Impaired Cardiometabolic Responses to Glucagon-Like Peptide 1 in Obesity and Type 2 Diabetes Mellitus

Glucagon-Like Peptide 1 (GLP-1) has insulin-like effects on myocardial glucose uptake which may contribute to its beneficial effects in the setting of myocardial ischemia. Whether these effects are different in the setting of obesity or type 2 diabetes (T2DM) requires investigation. We examined the...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Moberly, Steven P, Mather, Kieren J, Berwick, Zachary C, Owen, Meredith K, Goodwill, Adam G, Casalini, Eli D, Hutchins, Gary D, Green, Mark A, Ng, Yen, Considine, Robert V, Perry, Kevin M, Chisholm, Robin L, Tune, Johnathan D
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3731771/
https://ncbi.nlm.nih.gov/pubmed/23764734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00395-013-0365-x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki